Funabashi, Japan

Takashi Matsumoto


Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1993-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Inventor Takashi Matsumoto

Introduction

Takashi Matsumoto, an accomplished inventor based in Funabashi, Japan, has made significant strides in the field of pharmaceutical innovations. With a portfolio of six patents, he has been at the forefront of developing compounds that exhibit strong antiplatelet effects, thereby contributing to medical advancements in treating thrombotic diseases.

Latest Patents

Among Matsumoto's latest innovations are several patents related to pyrazolones and pyridazinone derivatives. The patents detail the chemical formulae for these derivatives, which are designed to function as antiplatelet agents. The specificity of his formulations allows for the potential treatment of various thrombotic conditions, showcasing strong efficacy and safety profiles. Notably, these compounds incorporate various structural components that optimize their therapeutic effects.

Career Highlights

Takashi Matsumoto is affiliated with Nissan Chemical Industries Limited, a pillar in the chemical sector known for its commitment to research and development. His work underlines a commitment to innovation that directly impacts healthcare, reflecting both his expertise and dedication to improving patient outcomes through his inventions.

Collaborations

In his career, Matsumoto has collaborated with notable colleagues such as Keizo Tanikawa and Nobutomo Tsuruzoe. These collaborations not only enhance the depth of research but also foster a collaborative environment that is essential for groundbreaking discoveries in the pharmaceutical industry.

Conclusion

Inventor Takashi Matsumoto has established himself as a leading figure in pharmaceutical innovation through his focus on antiplatelet agents. His contributions, characterized by a rich portfolio of patents, reflect a blend of creativity and scientific ambition. As he continues to work with esteemed colleagues at Nissan Chemical Industries Limited, the impact of his inventions promises to further advance the medical field in addressing thrombotic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…